Your browser doesn't support javascript.
Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortality.
Flook, M; Jackson, C; Vasileiou, E; Simpson, C R; Muckian, M D; Agrawal, U; McCowan, C; Jia, Y; Murray, J L K; Ritchie, L D; Robertson, C; Stock, S J; Wang, X; Woolhouse, M E J; Sheikh, A; Stagg, H R.
  • Flook M; Usher Institute, University of Edinburgh, 30 West Richmond Street, Edinburgh, EH8 9DX, UK.
  • Jackson C; Medical Research Council Clinical Trials Unit, University College London, London, UK.
  • Vasileiou E; Usher Institute, University of Edinburgh, 30 West Richmond Street, Edinburgh, EH8 9DX, UK.
  • Simpson CR; Usher Institute, University of Edinburgh, 30 West Richmond Street, Edinburgh, EH8 9DX, UK.
  • Muckian MD; School of Health, Wellington Faculty of Health, Victoria University of Wellington, Wellington, New Zealand.
  • Agrawal U; Usher Institute, University of Edinburgh, 30 West Richmond Street, Edinburgh, EH8 9DX, UK.
  • McCowan C; School of Medicine, University of St. Andrews, St. Andrews, UK.
  • Jia Y; School of Medicine, University of St. Andrews, St. Andrews, UK.
  • Murray JLK; Freelance consultant, Beijing, People's Republic of China.
  • Ritchie LD; National Health Service Fife, Kirkcaldy, UK.
  • Robertson C; Public Health Scotland, Glasgow, UK.
  • Stock SJ; School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK.
  • Wang X; Department of Mathematics and Statistics, University of Strathclyde, Glasgow, UK.
  • Woolhouse MEJ; Usher Institute, University of Edinburgh, 30 West Richmond Street, Edinburgh, EH8 9DX, UK.
  • Sheikh A; Usher Institute, University of Edinburgh, 30 West Richmond Street, Edinburgh, EH8 9DX, UK.
  • Stagg HR; Usher Institute, University of Edinburgh, 30 West Richmond Street, Edinburgh, EH8 9DX, UK.
BMC Infect Dis ; 21(1): 342, 2021 Apr 12.
Article in English | MEDLINE | ID: covidwho-1181089
ABSTRACT

BACKGROUND:

Severe Acute Respiratory Syndrome coronavirus-2 (SARS-CoV-2) has challenged public health agencies globally. In order to effectively target government responses, it is critical to identify the individuals most at risk of coronavirus disease-19 (COVID-19), developing severe clinical signs, and mortality. We undertook a systematic review of the literature to present the current status of scientific knowledge in these areas and describe the need for unified global approaches, moving forwards, as well as lessons learnt for future pandemics.

METHODS:

Medline, Embase and Global Health were searched to the end of April 2020, as well as the Web of Science. Search terms were specific to the SARS-CoV-2 virus and COVID-19. Comparative studies of risk factors from any setting, population group and in any language were included. Titles, abstracts and full texts were screened by two reviewers and extracted in duplicate into a standardised form. Data were extracted on risk factors for COVID-19 disease, severe disease, or death and were narratively and descriptively synthesised.

RESULTS:

One thousand two hundred and thirty-eight papers were identified post-deduplication. Thirty-three met our inclusion criteria, of which 26 were from China. Six assessed the risk of contracting the disease, 20 the risk of having severe disease and ten the risk of dying. Age, gender and co-morbidities were commonly assessed as risk factors. The weight of evidence showed increasing age to be associated with severe disease and mortality, and general comorbidities with mortality. Only seven studies presented multivariable analyses and power was generally limited. A wide range of definitions were used for disease severity.

CONCLUSIONS:

The volume of literature generated in the short time since the appearance of SARS-CoV-2 has been considerable. Many studies have sought to document the risk factors for COVID-19 disease, disease severity and mortality; age was the only risk factor based on robust studies and with a consistent body of evidence. Mechanistic studies are required to understand why age is such an important risk factor. At the start of pandemics, large, standardised, studies that use multivariable analyses are urgently needed so that the populations most at risk can be rapidly protected. REGISTRATION This review was registered on PROSPERO as CRD42020177714 .
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Risk Factors / COVID-19 Type of study: Diagnostic study / Prognostic study / Reviews / Systematic review/Meta Analysis Limits: Humans Country/Region as subject: Asia Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: S12879-021-05992-1

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Risk Factors / COVID-19 Type of study: Diagnostic study / Prognostic study / Reviews / Systematic review/Meta Analysis Limits: Humans Country/Region as subject: Asia Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: S12879-021-05992-1